Home arrow Cervical Cancer arrow Diagnosis of Anal Cancer Wednesday, 07 January 2009



 
Slick RSS
MedicineNet Cancer General
MedicineNet Cancer General
MedicineNet Logo
MedicineNet Depression General
MedicineNet Depression General
MedicineNet Logo
Cancer / Oncology News From Medical News Today
Latest Cancer / Oncology News From Medical News Today.
  • First RapidArc Radiotherapy Treatment In Italy Takes Place At Leading Milan Cancer Center
    A pancreatic cancer patient has become the first person in Italy to be treated using a new, faster form of radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. The Humanitas Clinic in Milan delivered the faster treatment using RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR). "We see three major benefits with RapidArc," added Dr. Marta Scorsetti, lead clinician at Humanitas.
  • Protein's Essential Role In Repairing Damaged Cells Revealed
    University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer. "Most proteins involved in responding to DNA damage that can cause cancer either help detect the damage and warn the rest of the cell, or help repair the damage," says David O. Ferguson, M.D., Ph.D., the study's lead author.
  • FDA Approves Drug For Patients With Advanced Prostate Cancer
    The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer. It belongs to a class of agents called gonadotropin releasing hormone (GnRH) receptor inhibitors. These agents slow the growth and progression of prostate cancer by suppressing testosterone, which plays an important role in the continued growth of prostate cancer.
  • Study Demonstrates That AHCC(R) Enhances Immune System By Increasing The Production Of Key Dendritic Cells
    A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
  • Differentiating Between Healthy Cells And Cancer Cells
    One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. But a new study by McMaster University researchers has provided insight into how scientists might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells Mick Bhatia, scientific director of the McMaster Stem Cell and Cancer Research Institute in the Michael G.